COBLL1 modulates cell morphology and facilitates androgen receptor genomic binding in advanced prostate cancer.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 29686105.
- Also identified by DOI 10.1073/pnas.1721957115 and PMC identifier 5948986.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Androgen receptor (AR) signaling is essential for prostate cancer progression and acquiring resistance to hormone therapy. However, the molecular pathogenesis through AR activation has not been fully understood. We performed integrative transcriptomic analysis to compare the AR program in a castration-resistant prostate cancer (CRPC) model with that in their parental hormone-sensitive cells. We found that the gene cordon-bleu-like 1 (<i>COBLL1</i>) is highly induced by AR in CRPC model cells. The expression of COBLL1 that possesses an actin-binding domain is up-regulated in clinical prostate cancer tissues and is associated with a poor prognosis for prostate cancer patients. COBLL1 is involved in the cancer cell morphogenesis to a neuron-like cell shape observed in the CRPC model cells, promoting cell growth and migration. Moreover, nuclear COBLL1 interacts with AR to enhance complex formation with CDK1 and facilitates AR phosphorylation for genomic binding in CRPC model cells. Thus, our findings showed the mechanistic relevance of cordon-bleu proteins during the AR-mediated progression to CRPC.
Medical subject headings
- Cell Movement
- Cell Nucleus
- Multiprotein Complexes
- Neoplasm Proteins
- Prostatic Neoplasms, Castration-Resistant
- Receptors, Androgen
- Transcription Factors